CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Peter J. McCormick

OPENALEX: A5056982766↗ORCID: 0000-0002-2225-5181↗

Affiliations

Organizations

Biomedical Research Networking Center on Neurodegenerative Diseasesauthorship · ES Norwich Research Parkauthorship · GB Queen Mary University of Londonauthorship · GB Universitat de Barcelonaauthorship · ES University of East Angliaauthorship · GB William Harvey Research Instituteauthorship · GB

Public evidence

3 connected articles

Identification of a Cannabinoid Receptor 2 Allosteric Site Using Computational Modeling and Pharmacological Analysis.2025 · Europe PMC Identification of BiP as a CB<sub>1</sub> Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse Brain.2021 · PubMed Central Open Access Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors2015 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Peter J. McCormick - Medical Cannabis Research Engine